诺卡菌属抗菌药物耐药表型与基因型分析
研究纳入以色列九家微生物实验室的138株诺卡菌临床分离株,用微量肉汤稀释法测定12种抗菌药物MIC,并对129株进行全基因组测序。结果显示利奈唑胺对所有分离株均有活性,甲氧苄啶/磺胺甲噁唑和妥布霉素耐药与特定耐药基因或突变相关,耐药呈菌种相关模式。
要点
- 利奈唑胺对所有138株诺卡菌均有活性。
- 甲氧苄啶/磺胺甲噁唑对93%的分离株有活性,阿米卡星对91%有活性。
- 耐药与特定基因相关,如aph(2″)、blaAST-1、blaFAR-1、gyrA Ser83Ala突变及16S rRNA m1A1408甲基转移酶。
核心结论
- 诺卡菌耐药呈菌种相关模式,提示耐药新发进化或传播的作用较小。
研究设计与样本
- 研究纳入来自以色列九家微生物实验室的138株诺卡菌临床分离株,对129株属于八种优势菌种的分离株进行全基因组测序。
- 采用微量肉汤稀释法测定12种抗菌药物的MIC值,并进行系统发育及耐药基因和突变分析。
主要发现
- 最常见菌种为Nocardia cyriacigeorgica(36%),其次为Nocardia farcinica(16%)、Nocardia wallacei(13%)、Nocardia abscessus(9%)和Nocardia brasiliensis(8%)。
- 利奈唑胺对所有分离株有活性,甲氧苄啶/磺胺甲噁唑对93%的分离株有活性,阿米卡星对91%的分离株有活性。
- aph(2″)见于N. farcinica和N. wallacei,与妥布霉素耐药相关;blaAST-1见于N. cyriacigeorgica和Nocardia neocaledoniensis,与阿莫西林/克拉维酸耐药相关。
- blaFAR-1见于N. farcinica,与头孢曲松耐药相关;gyrA基因Ser83Ala替换见于四种菌种,与环丙沙星耐药相关。
- 16S rRNA m1A1408甲基转移酶见于N. wallacei分离株,与阿米卡星耐药相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance is common in Nocardia species but data regarding the molecular mechanisms beyond their resistance traits are limited. Our study aimed to determine the species distribution, the antimicrobial susceptibility profiles, and investigate the associations between the resistance traits and their genotypic determinants. METHODS: The study included 138 clinical strains of Nocardia from nine Israeli microbiology laboratories. MIC values of 12 antimicrobial agents were determined using broth microdilution. WGS was performed on 129 isolates of the eight predominant species. Bioinformatic analysis included phylogeny and determination of antimicrobial resistance genes and mutations. RESULTS: Among the isolates, Nocardia cyriacigeorgica was the most common species (36%), followed by Nocardia farcinica (16%), Nocardia wallacei (13%), Nocardia abscessus (9%) and Nocardia brasiliensis (8%). Linezolid was active against all isolates, followed by trimethoprim/sulfamethoxazole (93%) and amikacin (91%). Resistance to other antibiotics was species-specific, often associated with the presence of resistance genes or mutations: (1) aph(2″) in N. farcinica and N. wallacei (resistance to tobramycin); (ii) blaAST-1 in N. cyriacigeorgica and Nocardia neocaledoniensis (resistance to amoxicillin/clavulanate); (iii) blaFAR-1 in N. farcinica (resistance to ceftriaxone); (iv) Ser83Ala substitution in the gyrA gene in four species (resistance to ciprofloxacin); and (v) the 16S rRNA m1A1408 methyltransferase in N. wallacei isolates (correlating with amikacin resistance). CONCLUSIONS: Our study provides a comprehensive understanding of Nocardia species diversity, antibiotic resistance patterns, and the molecular basis of antimicrobial resistance. Resistance appears to follow species-related patterns, suggesting a lesser role for de novo evolution or transmission of antimicrobial resistance.
引用
- Hershko Y, Levytskyi K, Rannon E, et al. Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species. J Antimicrob Chemother. 2023. PMID: 37527397. doi:10.1093/jac/dkad236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。